FDA Drug Application (200532) for OLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE by TEVA PHARMS USA INC

Back to FDA Applications sponsored by TEVA PHARMS USA INC

Application Number200532
Product Number001
FormTABLET; ORAL
Dosage20MG; 12.5MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameOLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE
Active IngredientOLMESARTAN MEDOXOMIL; HYDROCHLOROTHIAZIDE



Back to FDA Applications sponsored by TEVA PHARMS USA INC

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.